Investigational drug · Phase 2
TBO-309
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Ischemic Stroke, Tandem Occlusion.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 25, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "TBO-309"
First trial start
2025
Oct 4, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TBO-309", any sponsor or status.
Conditions studied
As listed on its trial records.
- Ischemic Stroke
- Tandem Occlusion
Approved drugs for the same conditions: Stroke prevention · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "TBO-309" as an intervention, largest first.
The Florey Institute of Neuroscience and Mental HealthAcademic, hospital or other
NCT05363397 · 80 participants (planned) · Start Sep 27, 2023 · Primary completion Feb 1, 2026
Drug: TBO-309 · For: Acute Ischemic Stroke
Sites: Camperdown, Australia; Liverpool, Australia; New Lambton Heights, Australia · 7 sites in all
ThromBio Pty. Ltd.Industry
NCT06813651 · 78 participants (planned) · Start Oct 4, 2025 · Primary completion Dec 30, 2026
Drug: TBO-309: 60 mg; TBO-309: 120 mg and 1 more · For: Ischemic Stroke; Tandem Occlusion
Sites: Newcastle, Australia; St Leonards, Australia
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Ischemic Stroke
- OtaplimastatSP-8203Phase 31 trial
Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke
- SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials
PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke
- Umbilical Cord Mesenchymal Stem CellsMesenchymal stromal cells, Allogeneic Mesenchymal Stem CellsPhase 24 trials
PT. Prodia Stem Cell Indonesia · Diabetic Nephropathy Type 2, Ischemic Stroke, Cerebral Palsy
- TS23Phase 22 trials
Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism
- NCS-01Phase 21 trial
NC Medial Research Inc · Ischemic Stroke
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.